TSXV:CLAS.H - Post by User
Post by
edroseon Apr 24, 2020 9:44am
90 Views
Post# 30948759
We know kly as great potential with great phase2 results the
We know kly as great potential with great phase2 results theResults where so good they didn’t have to use the higher dose since lower dose had extremely good results
I still think fda will ask for phase 3
kly’s biggest problem is poor management and board and conflict of interest since kly’s scientist like sagiv work for stero and kly
do you think bassada had access to phase 2 results BEFORE IT WAS MADE PUBLIC that’s why he could have started plan to take over kly that he just sold via talent
kly needs money and our board and management state that they tried ALL OPTIONS TO RAISE MONEY BUT THEY FAILED TO ATTRACT one yes one investor/or company that wanted to either be partner or be interested in LICENCING deal with upfront money;DONT forget first revenue is 500 million
also why not do rights offering to current kly investors months ago which would easily raise money to pay off talent